Flow Traders U.S.’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Flow Traders U.S.’s Portfolio LABD Stock Details LABD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,033	Closed	-$266K	–	910
2021 Q4	$266K	Buy	+1,033	New	+$238K	0.01%	644
2021 Q3	–	Sell	-2,080	Closed	-$401K	–	1098
2021 Q2	$401K	Buy	+2,080	New	+$466K	0.02%	651
2021 Q1	–	Sell	-4,920	Closed	-$1.24M	–	906
2020 Q4	$1.24M	Buy	+4,920	New	+$1.88M	0.09%	201
2020 Q3	–	Sell	-707	Closed	-$491K	–	588
2020 Q2	$491K	Buy	+707	New	+$888K	0.04%	294
2017 Q1	–	Sell	-4	Closed	-$154K	–	428
2016 Q4	$154K	Buy	+4	New	+$154K	0.01%	295
2016 Q3	–	Sell	-2	Closed	-$93.5K	–	373
2016 Q2	$122K	Sell	2 -22	-92%	-$1.77M	0.01%	205
2016 Q1	$2.5M	Buy	+24	New	+$3.07M	0.25%	58

Other funds holding LABD

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SCM

Southport Capital Management Chattanooga, Tennessee $274M AUM 28.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Flow Traders U.S.'s LABD Position: Q1 2022 in Review

Flow Traders U.S. sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2022, closing a stake of 1,033 shares — an estimated $266K sold.

Flow Traders U.S. first reported a position in LABD in Q1 2016 and held it in 7 quarters. The position peaked at $2.5M in Q1 2016. 17 funds tracked by Wall St. Rank hold LABD as of Q1 2022.

Flow Traders U.S. reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2022 after selling out during the quarter.
Flow Traders U.S. sold 1,033 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2022, an estimated $266K.
Flow Traders U.S. first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2016 and held it in 7 quarters.
Flow Traders U.S.'s Direxion Daily S&P Biotech Bear 3X ETF position peaked at $2.5M in Q1 2016.
17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2022.

Based on Flow Traders U.S.'s 13F filing for Q1 2022, filed 13 May 2022.